FHOD3-MS4A15 Fusion FISH Probe
The FHOD3-MS4A15 Fusion FISH Probe is used to confirm a fusion of the FHOD3 and MS4A15 genes. The fusion of the FHOD3 and MS4A15 genes has been associated with Head And Neck Squamous Cell Carcinoma . These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FHOD3-MS4A15-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FHOD3-MS4A15-20-AQAQ | 20 (40 μL) | 200 μL |
|
FHOD3 Gene Summary
The protein encoded by this gene is a member of the diaphanous-related formins (DRF), and contains multiple domains, including GBD (GTPase-binding domain), DID (diaphanous inhibitory domain), FH1 (formin homology 1), FH2 (formin homology 2), and DAD (diaphanous auto-regulatory domain) domains. This protein is thought to play a role in actin filament polymerization in cardiomyocytes. Mutations in this gene have been associated with dilated cardiomyopathy (DCM), characterized by dilation of the ventricular chamber, leading to impairment of systolic pump function and subsequent heart failure. Increased levels of the protein encoded by this gene have been observed in individuals with hypertrophic cardiomyopathy (HCM). Alternative splicing results in multiple transcript variants encoding different isoforms. A muscle-specific isoform has been shown to possess a casein kinase 2 (CK2) phosphorylation site at the C-terminal end of the FH2 domain. Phosphorylation of this site alters its interaction with sequestosome 1 (SQSTM1), and targets this isoform to myofibrils, while other isoforms form cytoplasmic aggregates. [provided by RefSeq, Aug 2015]
Gene Name: Formin Homology 2 Domain Containing 3
Chromosome: CHR18: 33877701 -34360018
Locus: 18q12.2
MS4A15 Gene Summary
The Membrane Spanning 4-domains A15 (MS4A15) gene is located on chr11 :60524339-60544204 at 11q12.2.
Gene Name: Membrane Spanning 4-domains A15
Chromosome: CHR11: 60524339 -60544204
Locus: 11q12.2
Gene Diseases
The FHOD3 MS4A15 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Head And Neck Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|